Procter & Gamble saw the highest growth of 119% in patent filings in February and 127% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 82% and grants by 118%. GlobalData’s DataBook provides a comprehensive analysis of Procter & Gamble’s patent filings and grants. Buy the databook here.
Procter & Gamble has been focused on protecting inventions in United States(US) with 370 publications in Q1 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 41% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Procter & Gamble is filings its patents. Among the top granted patent authorities, Procter & Gamble has 41% of its grants in United States(US), 18% in European Patent Office(EPO) and 11% in Japan(JP).
Novonesis Group could be the strongest competitor for Procter & Gamble
Patents related to healthtech and circular economy lead Procter & Gamble's portfolio
Procter & Gamble has the highest number of patents in healthtech followed by, circular economy and climate change. For healthtech, nearly 16% of patents were filed and 4% of patents were granted in Q1 2024.
Cosmetics & toiletries related patents lead Procter & Gamble portfolio followed by household care, and diapers
Procter & Gamble has highest number of patents in cosmetics & toiletries followed by household care, diapers, sanitary pads, and packaging. For cosmetics & toiletries, nearly 17% of patents were filed and 15% of patents were granted in Q1 2024.
For comprehensive analysis of Procter & Gamble's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.